Blueprint MedTech Translator (UG3/UH3)

The purpose of this grant is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems.

Funding: No fixed limit 

Duration: 5 years total (each phase up to 4 years) 

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due date: 18.12.21, 20.4.22, 18.8.22, 21.12.22, 19.4.23, 18.8.23, 20.12.23, 20.4.24

Full proposal due date: 20.10.21, 18.2.22, 20.6.22, 18.10.22, 21.2.23, 19.6.23, 18.10.23, 20.2.24, 20.6.24